Sectors
Bosch and Sumitomo have kicked in for the internet-of-things technology developer's latest round, which comes almost 18 months after its Nokia-backed series A.
The workplace productivity software developer has now raised $26.5m altogether, with Bloomberg Beta investing in the company for a third time.
The cloud-based drug prescription platform has closed a round that included new investor GV and SR One, a backer since seed stage.
Medical technology developer Onkos Surgical has raised $17.6m from investors including 3D printing equipment provider 3D Systems.
Augmented reality technology developer Avegant has added $13.7m from backers including Intel Capital and Applied Materials to a round that now total $37.7m.
Aetna Ventures, GV and MassMutual Ventures have committed funds to the latest round for cyberthreat detection platform CyberGRX.
Boston Scientific has led a $23.1m series B round for Neurotronik, a medical device devloper focusing on patients suffering from heart failure.
Qiang Sen has welcomed back series A investor Legend Capital for a $14.5m round that will fund the expansion of its chain of community healthcare clinics.
Tonghua Dongbao Pharmaceutical and Legend Holdings are among the investors in a series B round for wearable medical device maker Zhejiang PocTech Medical.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
